Therefore, IL-15 has gradually emerged as an alternative to IL-2 in cancer treatment by reason of its functional similarity to IL-2 with several added benefits (the difference between IL-12 and IL-15 is shown in Table 1) (Yang and Lundqvist, 2020). The gene discussed is IL15; the disease is cancer.